-
Symbol
-
LVTX on Nasdaq
-
Investment type
-
Equity / Common shares, Euro 0.12 nominal value per share
-
Latest Disclosed Ownership
-
0 shares
-
Security Ownership
-
0%
Versant Venture Capital VI, L.P. ownership in LAVA Therapeutics NV Common shares, Euro 0.12 nominal value per share (LVTX)
2025-09-23 - Versant Venture Capital VI, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of LAVA Therapeutics NV Common shares, Euro 0.12 nominal value per share (LVTX).
This represents 0% percent ownership of the company.
In their previous filing dated 2025-09-18, Versant Venture Capital VI, L.P. had reported owning 2.37M shares, indicating a decrease of -100% percent.